Trodelvy and bladder cancer: what to know

Treatment is given through a vein in an oncology setting, with the schedule and dose tailored to you. Possible effects include low blood counts, nausea, diarrhoea, tiredness, hair loss, reduced appetite, and infusion-related reactions. Your team may use blood tests and symptom checks before treatment. Trodelvy is different from standard [Chemotherapy](/treatments/systemic-therapy/chemotherapy/) in how the medicine is directed, although it can still affect healthy cells.

Bring a list of medicines, allergies, and previous cancer treatments. Ask whether your tumour tests and treatment history make Trodelvy suitable, what supportive medicines you will receive, and how blood counts will be monitored. Keep fluids available, follow anti-sickness instructions, and report new diarrhoea or fever promptly. Other options may include [Immunotherapy](/treatments/systemic-therapy/immunotherapy/) or surgery in selected situations.

Contact your cancer team urgently for a fever, chills, breathing difficulty, facial swelling, severe weakness, uncontrolled vomiting, persistent diarrhoea, unusual bleeding, or confusion. Difficulty passing urine needs prompt assessment, especially with pain, vomiting, or very little urine; see [Difficulty Passing Urine](/symptoms/difficulty-passing-urine/).

Which treatment goal applies to me? What tests support this choice? How will you manage low blood counts and digestive symptoms? What should I do if I miss an appointment or feel unwell?